Therapeutic adjustments in stage D heart failure: challenges and strategies.

about

Therapeutic adjustments in stage D heart failure: challenges and strategies.

Item

http://www.wikidata.org/entity/Q38267665

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Therapeutic adjustments in stage D heart failure: challenges and strategies.

@en

type

Item

label

Therapeutic adjustments in stage D heart failure: challenges and strategies.

@en

prefLabel

Therapeutic adjustments in stage D heart failure: challenges and strategies.

@en

P1476

Therapeutic adjustments in stage D heart failure: challenges and strategies.

@en

P2093

Anju Nohria

http://www.w3.org/2001/XMLSchema#string

Emer Joyce

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Medical management of advanced heart failure.

Chronic inotropic therapy in end-stage heart failure.

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Long-term use of a left ventricular assist device for end-stage heart failure.

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.

P2888

s11897-014-0240-6

P304

15-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11897-014-0240-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1053612270

http://www.w3.org/2001/XMLSchema#string

P698

25391351

http://www.w3.org/2001/XMLSchema#string